25.66
전일 마감가:
$25.59
열려 있는:
$25.49
하루 거래량:
765.03K
Relative Volume:
0.59
시가총액:
$1.97B
수익:
$1.29B
순이익/손실:
$67.69M
주가수익비율:
33.32
EPS:
0.7701
순현금흐름:
$184.42M
1주 성능:
-0.62%
1개월 성능:
-17.57%
6개월 성능:
+45.05%
1년 성능:
+8.41%
Progyny Inc Stock (PGNY) Company Profile
명칭
Progyny Inc
전화
212-888-3124
주소
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PGNY
Progyny Inc
|
25.66 | 1.99B | 1.29B | 67.69M | 184.42M | 0.7701 |
|
UNH
Unitedhealth Group Inc
|
396.30 | 345.44B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
97.60 | 119.78B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
403.04 | 85.94B | 201.11B | 4.95B | 6.29B | 22.50 |
|
CI
Cigna Group
|
283.06 | 72.51B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
394.88 | 45.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-20 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2026-01-08 | 업그레이드 | Truist | Hold → Buy |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-12 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-13 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-19 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-08-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | 개시 | JMP Securities | Mkt Outperform |
| 2024-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-09-27 | 개시 | Canaccord Genuity | Buy |
| 2023-05-22 | 개시 | BTIG Research | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-05 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | 개시 | Truist | Buy |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-09-30 | 개시 | Berenberg | Buy |
| 2021-08-12 | 개시 | Barclays | Overweight |
| 2021-06-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-04-29 | 재개 | JP Morgan | Overweight |
| 2021-03-10 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-01 | 개시 | SVB Leerink | Outperform |
| 2020-06-02 | 개시 | Guggenheim | Buy |
| 2019-11-19 | 개시 | Citigroup | Buy |
| 2019-11-19 | 개시 | Goldman | Buy |
| 2019-11-19 | 개시 | JP Morgan | Overweight |
| 2019-11-19 | 개시 | Piper Jaffray | Overweight |
| 2019-11-19 | 개시 | SVB Leerink | Outperform |
모두보기
Progyny Inc 주식(PGNY)의 최신 뉴스
Progyny (NASDAQ:PGNY) Healthcare Innovation Gains Attention - Kalkine Media
PGNY Maintained by JP Morgan -- Price Target Raised to $30.00 - GuruFocus
JPMorgan Chase & Co. Boosts Progyny (NASDAQ:PGNY) Price Target to $30.00 - MarketBeat
Progyny (NASDAQ:PGNY) Upgraded at Wells Fargo & Company - MarketBeat
Tocqueville Asset Management L.P. Takes Position in Progyny, Inc. $PGNY - MarketBeat
Danske Bank A S Purchases Shares of 528,717 Progyny, Inc. $PGNY - MarketBeat
PGNY Initiated Coverage by Wells Fargo -- Rating Overweight Anno - GuruFocus
Progyny (PGNY) Q2 2026 Earnings Call Transcript - AOL.com
Wells Fargo Initiates Progyny at Overweight With $37 Price Target - marketscreener.com
Wells Fargo Initiates Progyny(PGNY.US) With Buy Rating, Announces Target Price $37 - Moomoo
Progyny (NASDAQ:PGNY): A Decent Value Stock Combining Reasonable Valuation and Solid Fundamentals - ChartMill
Bank of America Corp DE Grows Stake in Progyny, Inc. $PGNY - MarketBeat
Progyny (PGNY) Session Brief: Gains 1.76% to Reach $25.77 at the Close; Chart Reference: the Current Price Sits Inside the Supplied Technical Range in the Current UpdateMoving Average Ribbon - vinanet.vn
symbol__ Stock Quote Price and Forecast - CNN
Discipline and Rules-Based Execution in PGNY Response - Stock Traders Daily
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook - marketbeat.com
Royal Bank of Canada Has $3.71 Million Stock Position in Progyny, Inc. $PGNY - MarketBeat
The 5 Most Interesting Analyst Questions From Progyny’s Q2 Earnings Call - Yahoo Finance
Truist Financial Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $36 - moomoo.com
PGNY Maintains Buy Rating -- Price Target Raised to $36.00 by Tr - GuruFocus
Truist raises Progyny price target to $36 after strong Q2 results and growing institutional support - Pluang
Truist Adjusts Price Target on Progyny to $36 From $33, Maintains Buy Rating - Moomoo
Progyny Inc (PGNY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Progyny, Inc. (PGNY) Stock Forecasts - Yahoo Finance
PGNY Maintains Rating by Barclays -- Price Target Lowered to $30 - GuruFocus
Sei Investments Co. Decreases Stake in Progyny, Inc. $PGNY - MarketBeat
Progyny Inc (PGNY) Stock Down 4.6% -- Now Undervalued? GF Score: 93/100 - GuruFocus
Progyny Drops 5.4% Amid Sector-Wide Selling - AlphaStreet
Progyny, Inc. $PGNY Shares Sold by Janus Henderson Group PLC - MarketBeat
Progyny, Inc. (PGNY) Stock Analysis: Examining The 21% Potential Upside - DirectorsTalk Interviews
Why Progyny (PGNY) Shares Are Sliding Today - finance.yahoo.com
Progyny (PGNY) Stock May Still Trade At A Discount As Earnings Hold Up - Yahoo Finance
Quantinno Capital Management LP Grows Position in Progyny, Inc. $PGNY - MarketBeat
PGNY Q2 CY2026 Deep Dive: Seasonality and Guidance Weigh on Positive Underlying Performance - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Progyny (PGNY), Scholar Rock Holding (SRRK) and Ascendis Pharma (ASND) - The Globe and Mail
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $31 to $35 - Moomoo
Progyny (PGNY) Stock Sinks As Guidance Jitters Clash With Margin Strength - simplywall.st
PGNY SWOT Analysis: Strong Growth Potential Revealed in 10-Q Fil - GuruFocus
Progyny Inc (PGNY) Stock News Today - TradingKey
Progyny Posts Record Q2 Results, Expands Client Base - The Globe and Mail
CCORF Maintains Progyny(PGNY.US) With Buy Rating, Cuts Target Price to $35 - moomoo.com
Progyny, Inc. Releases Q2 2026 Form 10-Q Filing Highlighting Financials and Risks - kalkinemedia.com
Why Progyny Stock Plunged, Then Gradually Recovered Today - AOL.com
Progyny CEO to present at Canaccord Genuity Ann... - Pluang
Progyny (NASDAQ:PGNY) Shares Gap DownHere's What Happened - MarketBeat
Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference - GlobeNewswire
Progyny, Inc. 2026: Revenue $350.51M, EPS $0.34— 10-Q Summary - TradingView
Progyny, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Progyny, Inc. Stock 12‑Month Price Target Cut to $33.82, Implies 12% Upside - TradingView
Progyny Q2 2026 Earnings Call Transcript - MarketBeat
Progyny, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PGNY) 2026-08-07 - Seeking Alpha
Progyny Inc (PGNY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):